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Background: HIV-1 p24 antigen is a major viral component of human immunodeficiency virus type 1 (HIV-1) which
can be used to identify persons in the early stage of infection and transmission of HIV-1 from infected mothers to
infants. The detection of p24 is usually accomplished by using an enzyme-linked immunosorbent assay (ELISA) with
low detection sensitivity. Here we report the use of two bio-barcode amplification (BCA) assays combined with
polymerase chain reaction (PCR) and gel electrophoresis to quantify HIV-1 p24 antigen.
Method: A pair of anti-p24 monoclonal antibodies (mAbs) were used in BCA assays to capture HIV-1 p24 antigen in
a sandwich format and allowed for the quantitative measurement of captured p24 using PCR and gel
electrophoresis. The first 1 G12 mAb was coated on microplate wells or magnetic microparticles (MMPs) to capture
free p24 antigens. Captured p24 in turn captured 1D4 mAb coated gold nanoparticle probes (GNPs) containing
double-stranded DNA oligonucleotides. One strand of the oligonucleotides was covalently immobilized whereas
the unbound complimentary bio-barcode DNA strand could be released upon heating. The released bio-barcode
DNA was amplified by PCR, electrophoresed in agarose gel and quantified.
Results: The in-house ELISA assay was found to quantify p24 antigen with a limit of detection (LOD) of 1,000 pg/ml
and a linear range between 3,000 and 100,000 pg/ml. In contrast, the BCA-based microplate method yielded an
LOD of 1 pg/ml and a linear detection range from 1 to 10,000 pg/ml. The BCA-based MMP method yielded an LOD
of 0.1 pg/ml and a linear detection range from 0.1 to 1,000 pg/ml.
Conclusions: When combined with PCR and simple gel electrophoresis, BCA-based microplate and MMPs assays
can be used to quantify HIV-1 p24 antigen. These methods are 3–4 orders of magnitude more sensitive than our
in-house ELISA-based assay and may provide a useful approach to detect p24 in patients newly infected with HIV.
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The early stage of HIV infection is characterized by the
absence of detectable antibodies and transient high viral
load. Patients in this window period have a high prob-
ability of HIV transmission [1,2]. Virologic markers such
as HIV-1 RNA, DNA and p24 antigen can be used to
determine infection status. The direct detection of viral
nucleic acids using PCR-based approaches is of high
technical complexity and requires skilled personnel, equip-
ment and laboratory infrastructure. It is also complicated* Correspondence: jiangyan03@263.net
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reproduction in any medium, provided the orby the high variation and continuing diversification of
HIV viral genome and subtypes [3-5]. Detection of p24
antigen could serve as a viable alternative for the detec-
tion of infection during the window period [6-8] and in
HIV-1 exposed infants [9,10].
ELISA has been previously used for HIV-1 p24 antigen
detection. Due to the interference of antibodies in
infected persons, conventional ELISA assays can detect
p24 in approximately 10% asymptomatic infected per-
sons and 30 to 40% patients with late stage AIDS-related
syndrome [11]. Several modifications have been intro-
duced to improve detection sensitivity by heat or acid
disruption of antigen-antibody complexes [12], signal
amplification based on tyramide [13] and immuno-PCRtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cently developed to detect proteins with special clinical
significance [15]. To capture the antigen of interest,
MMPs of 1 μm in diameter are coated with a mAb to
the antigen. Addition of GNPs dually labeled with a sec-
ond mAb and bio-barcode DNA oligomers results in
the formation of an antigen, antibody, DNA oligomer
complex. The amount of the DNA oligomers co-captured
is directly proportional to the amount of the antigen
and can be quantitatively measured by chip-based
scanometric method [15-20] and PCR [21,22]. Here
we describe the use of two types of BCA assay with
simple PCR and gel analysis to achieve HIV-1 p24
quantification.Results
Detection of HIV-1 p24 antigen by ELISA
First, we examined the quantification of p24 antigen
using an in-house ELISA assay with 1 G12 and 1D4
mAb pair (Figure 1A). Serial dilutions of p24 antigens
from 100,000 to 100 pg/ml were added to the micro-
plate wells precoated with 1 G12 mAb and then incu-
bated with horseradish peroxidase labeled 1D4 mAb for
colorimetric reaction. The average of 3 independent
OD450 measurements of negative controls was 0.249
(standard deviation SD= 0.014) and the cutoff (CO)
was 0.291 (= mean plus 3SD). The SD (Figure 2) and
coefficient of variations (1.6–22.2%) of the data point
range were small. The LOD was 1, 000 pg/ml (Figure 2).
The signal and antigen response curve increased slowly
and was linear in the range between 3,000 and
100,000 pg/ml (Figure 3A).PCR and gel detection of signal strand of bio-barcode
DNA
To improve the p24 detection sensitivity, we employed
two types of BCA methods to capture p24 and then used
PCR and gel electrophoresis to measure the amount of
amplified bio-barcode DNA (Figure 1 B and C). To dem-
onstrate the utility of PCR and gel electrophoresis to
measure the bio-barcode DNA oligomer, we used un-
bound free single-stranded bio-barcode DNA oligomer
(3 × 109 to 30 copies), amplified with a bio-barcode
DNA specific primer pair for 25 cycles and examined
the amplified product in a 4% agarose gel. As shown
in Figure 4, clear DNA bands with anticipated 47 bp
in length were detected in samples with input DNA
of 3 × 109 to 3,000 copies (lanes 1 ~ 7) but not in
samples with input DNA of 300 copies and 30 copies
(lanes 8 and 9, respectively). No bands or primer
dimers were found after 25 cycles of PCR for the
negative control (lane 10).Detection of HIV-1 p24 antigen by BCA using microplate
With the establishment of the method to measure bio-
barcode oligomer using PCR and gel electrophoresis, we
proceeded with the BCA-based microplate assay
(Figure 1B). Serial dilutions (0.1 to 10,000 pg/ml) of
HIV-1 p24 antigen were added onto microplate wells
precoated with 1 G12 mAb followed by the addition of
GNPs. The amount of bio-barcode DNA on the cap-
tured GNPs was measured by PCR and gel electrophor-
esis. The signal of the 47 bp PCR products in 3
independent experiments were measured. The cutoff
value was 0.098 (mean plus 3 SD). The SD (Figure 2)
and coefficient of variations (3.4–13.1%) of the entire
data point range were small. The LOD of this assay was
1 pg/ml (Figure 2) and the linear detection range of p24
was from 1 to 10,000 pg/ml (Figure 3B).
Detection of HIV-1 p24 antigen by BCA using MMPs
We further substituted the microplate with magnetic
microparticles to increase the binding kinetics between
the p24 antigen and capture mAb (Figure 1C). The
measurement of p24 by PCR and gel electrophoresis
remained the same as described above. The cutoff value
was 0.125 (mean of 3 determinations and 3 SD). The SD
(Figure 2) and coefficient of variations (2.5-10.3%) of the
entire data point range were small. The LOD of this
assay was improved to 0.1 pg/ml (Figure 2) and the lin-
ear detection range of p24 was from 0.1 to 1,000 pg/ml
of p24 (Figure 3C).
Discussion
BCA-based assays have become a new platform fre-
quently used to detect trace proteins requiring high
sensitivity detection [18,23,24]. It has been applied to
the early diagnosis of cancer markers and infectious
diseases such as prostate-specific antigen (PSA) [15,16],
human chorionic gonadotropin and α-fetoprotein [25],
amyloid-ß-derived diffusible ligand [26], interleukin-2
[23], Hantaan viral nucleocapsid protein [22] and HIV-1
p24 antigen [17,19,21]. Likewise, here we showed that
BCA-based microplate and MMP assays coupled with
PCR signal amplification offer greater detection sensi-
tivity over an ELISA assay by 1,000 to 10,000 fold,
respectively. The increase of signal is achieved by (1) the
large number of bio-barcode DNA oligomer coated onto
the GNPs [20,25] and (2) PCR amplification of the bio-
barcode DNA released from the GNPs after specific p24
and mAb capture.
Several forms of signal amplification methods have
been used including chip-based scanometric detection
[15,19,25,26], colormetric method [23], and fluorescent
approach [20]. Kim and colleagues used MMPs and
compared real-time PCR and chip-based methods. They
found that the two methods performed similarly and
Figure 1 Schematic illustrations of two biobarcode amplification (BCA) assays and ELISA assay to detect HIV-1 p24 antigen. (A) ELISA,
(B) Microplate [22] and (C) MMPs methods. The detailed description of the methods is described in Materials and Methods. The enzyme (E) used
in the ELISA assay was horse radish peroxidase.
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from 0.1 pg/ml to 10,000 pg/ml [21]. Tang used a BCA-
based microplate assay combined with chip-based
method to achieve an LOD of HIV-1 p24 at 0.1 pg/ml
with the linear range of 0.1–500 pg/ml [19]. In an at-
tempt to simplify assay procedures and shorten the reac-
tion time, Tang et al., used europium nanoparticles to
replace GNPs, but the LOD increased from 0.1 to
0.5 pg/ml [17]. In this report, we showed that our MMP
assay was reproducible with small SD and CV. It
achieved 10-fold detection sensitivity over that of the
microplate method. Our MMP assay has comparatively
simpler operation and shorter reaction time than those
reported earlier [21] and we achieved the same LOD and
a wider linear range of 0.1 to 1,000 pg/ml in two hours.One of the disadvantages of PCR-based methods is
the potential of cross-contamination. Although this
phenomenon was not observed in our study, measures
to avoid PCR contamination should be strictly observed
[27,28]. We had attempted the use of real-time PCR with
SYBR Green to replace gel-based quantification but we
found the magnitude of signal amplification over the
intended detection range of p24 was suboptimal (data
not shown). One of the important applications of p24
detection in China is to identify HIV-infected infants
born to HIV-infected mothers. Currently there is no
government-approved domestic HIV-1 p24 or nucleic
acid-based technologies available. We will continue im-
proving the current procedures by identifying a better
mAb pair for the p24 and GNP complex formation and
Figure 2 Relative HIV-1 p24 antigen detection sensitivity using 2 BCA-based assays and an in-house ELISA assay. The X axis represents
serial dilutions (log10) of HIV-1 p24 antigen, the left Y axis is OD450 value for ELISA, and the right Y axis is the DNA amounts (pmoles) calculated
from gel electrophoresis band of samples for the two BCA assays. Each data point represents the average of 3 independent determinations.
Squares : ELISA, circles: microplate method, and triangles: MMPs method.
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for the accurate and rapid identification of HIV infection.
Conclusions
Our current study demonstrated that when combined
with PCR and gel analysis, BCA-based assays using
microplates and MMPs can detect HIV-1 p24 antigen 3
to 4 orders of magnitude more sensitive than the con-
ventional ELISA assay and offers a wide linear dynamic
range. This assay may be useful in China to detect HIV
infection in infants born to HIV-infected mothers.
Materials and methods
HIV p24 antigen and its monoclonal antibodies
HIV-1 p24 recombinant antigen was purchased from
GenWay Biotech (San Diego, CA). Mouse anti-p24
monoclonal antibody, 1 G12 and 1D4, and their cor-
responding horseradish peroxidase-labeled mAbs were
purchased from Jing Tiancheng biology company
(Beijing, China). These two mAbs recognize different
p24 epitopes. The 1 G12 mAb was used to capture
p24 and 1D4 mAb was used as the secondary anti-
body for signal detection.
Oligonucleotides and reagents
Bio-barcode DNA was 47-base in length and its se-
quence, 5’-CAGCTGGTCAGCAGAATGGTGTGACCCT
CATGGCCGTCTTATCGGGT-3’, was derived from
AT4G27630.1 (accessed December 25, 2011 at http://
www.arabidopsis.org/index.jsp). Capture DNA sequence
is complementary to the Bio-barcode DNA with an addition
of an SH group and 15 A residues at its 5’ end. The forward
primer (5’-CAGCTGGTCAGCAGAATGGTG-3’) and re-
verse primer (5’-ACCCGATAAGACGGCCATGAG-3’)
were used for the PCR amplification of bio-barcode DNA.All oligonucleotides were purchased from Sangon Co. Ltd.
(Shanghai, China). PCR reagents were purchased from
TaKaRa Biotechnology Co., Ltd (Dalian, China). Gold
nanoparticles of 30 nm in diameter and tosyl-activated
magnetic microparticles (MyOne™ DynabeadsW) were pur-
chased from Ted Pella Inc (Redding, CA) and Invitrogen
(Carlsbad, CA), respectively.
Preparation of functionalized MMPs
MyOne™ DynabeadsW were conjugated with 1 G12 mAb
according to manufacturer’s protocol. Briefly, 40 μl
1 G12 mAb (1 mg/ml), 10 μl magnetic microparticles,
42 μl 3 M (NH4) 2SO4 and 66 μl borate buffer (0.1 M,
pH 9.5) were combined in a 1.5 ml tube and incubated
at 37°C at 1400 oscillations per minute for 24 h. The
MMPs were separated from unbound components mag-
netically. Three hundred μl of blocking buffer consisting
of phosphate-buffered saline (PBS), pH 7.4, 10% BSA
and 0.05% Tween 20 was added and the MMPs mixture
was incubated at 37°C at 1400 oscillations per minute
for another 24 h. At the completion of incubation, the
MMPs were separated magnetically and were washed
twice with 1 ml of magnetic-probe solution containing
PBS pH 7.4, 0.1% BSA and 0.05% Tween 20, and resus-
pended in 200 μl of the same solution and stored at 4°C
until use. Functionalized MMPs retained their antigen
binding activity for 4–6 months
Preparation of functionalized GNPs
GNPs functionalized with 1D4 mAb and the capture
DNA oligomers were prepared as described previously
[22]. Briefly, the pH of GNPs in aqueous solution
(330 pM) was first adjusted to pH 9.2 with 1 N NaOH.
One ml of the solution was incubated with 6 μg 1D4 mAb
Figure 3 Linear dynamic p24 detection ranges of three assays:
(A) in-house ELISA, (B) BCA-based microplates and (C)
BCA-based MMPs. Each data point represents the average of three
independent determinations. Statistical analysis of linear regression
model between the signal value of each methods and the
concentration of HIV-1 p24 are carried out with SPSS 16.0.
Figure 4 Amplification detection of 10-fold diluted bio-barcode
is revealed by 4% agarose gel electrophoresis. The
concentration of DNA in lane 1 was 0.005 uM and 5 μl of PCR DNA
were used for gel electrophoresis. Lane M is the 20 bp ladder
reference DNA marker (Takara Inc.). Lanes 1 to 9 represents
amplicons 3 × 109, 3 × 108, 3 × 107, 3 × 106, 3 × 105, 3 × 104, 3 × 103,
300, and 30 copies of signal bio-barcode DNA. Lane 10 represents
negative control (PCR reaction mixture without input DNA).
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addition of 57.7 μg capture DNA oligomer at 10°C for
16 h. The salt concentration was then adjusted to 0.1 M
using 2 M NaCl followed with the addition of 0.3 ml of
10% BSA. The mixture was incubated at 22°C for
30 min and then centrifuged at 10,000 rpm at 4°C for
30 min. The supernatant was removed and the GNPs
were resuspended and washed once with 0.01 M PBS.
The particles were resuspended with 400 μl PBS con-
taining 65.5 μg of the signal DNA oligomers and allowed
to hybridize at 37°C for 1 h. Finally, the GNPs were cen-
trifuged at 10,000 rpm (Eppendorf centrifuge 5415 R,
Germany) at 4°C for 30 min and then resuspended in
PBS containing 0.01% (v/v) Tween 20 and 0.1% (w/v)
BSA. The functionalized GNPs solution was stored at
4°C until use.Detection of HIV-1 p24 antigen by ELISA
Microplate strips (Corning Costar Inc., Lowell, MA)
were coated with 100 μl per well of 1 G12 mAb (5 μg/ml
in 0.5 M carbonate buffer) at 4°C for 24 h. After incuba-
tion, the strips were washed twice with PBS and then
treated with 10% BSA at 37°C for 24 h to block the sur-
face. The strips were washed again and then coated with
100 μl per well of serially diluted p24 antigen (ranged
from 0.1 to 100,000 pg/ml) by incubating at 37°C for
1.5 h. Unbound antigens were washed 3 times with PBS.
One hundred μl of 1,000 fold diluted HRP-labeled 1D4
was added to each well and the plate was incubated at
37°C for 1 h followed with 6 washes with PBS. One hun-
dred μl of tetramethylbenzidine was then added to each
well and the plate was incubated at 22°C for 15 min. The
enzymatic reaction was terminated with the addition of
50 μl of 2 M H2SO4, and the color was quantified in an
ELx808 plate reader (BioTek, Seattle, WA) at the wave-
length of 450 nm.
Detection of HIV-1 p24 antigen by BCA based on
microplate
The assay scheme is shown in Figure 1B. The coating of
BCA and blocking processes of microplates were the
same as in ELISA. One hundred μl of 10 fold serially
diluted HIV-1 p24 (0.1 to 10,000 pg/ml) in PBS contain-
ing 3% BSA was added into 1 G12 mAb coated wells.
After incubation at 37°C for 60 min, the wells were
washed 5 times with PBS containing 5 mM EDTA and
0.05% (v/v) and Tween 20 (PBSET). Then 100 μl GNPs
(with a final concentration of 50 pM in 10% BSA) were
added into each well and incubated at 37°C for 20 min.
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with PBS and once with 50 μl of Milli-Q distilled water.
Finally, the wells were membrane sealed and heated in a
water bath at 80°C for 5 min to release the captured sig-
nal DNA oligomers.
PCR amplification was performed by adding 1 μl of
the free bio-barcode DNA solutions as templates. Total
volume of the PCR reaction mixture was 25 μl contain-
ing 2.5 μL 10x Ex Taq Buffer (Mg2+), 2 μl dNTPs
(2.5 mM each), 0.5 μl each of forward and reverse pri-
mers (with final concentration of 20 μM each), 1 μl
Bio-barcode DNA, and 0.8 unit of TaKaRa Ex Taq poly-
merase. PCR reaction was run on Veriti 96-well thermal
Cycler (Applied Biosystems, Foster City, CA) with the
following temperature profile: initial denaturation, 95°C,
1 min; 25 cycles of denaturation (95°C, 30 s), annealing
(54°C, 30 s), and extension (72°C, 45 s); and final exten-
sion (72°C, 5 min). Five μl of the PCR product was elec-
trophoresed in a 4% agarose gel and the signal of the
amplified 47-bp bio-barcode DNA was measured using
GeneGenius Gel Imaging System (Syngene, Cambridge,
UK) and BandScan version 5.0 [29,30]. The 100 bp
DNA band of the 20 bp DNA Ladder (Takara, Dalian,
China) standard with known input amount prior to gel
electrophoresis was used as the DNA reference. The
gray scale of electrophoresed 47 bp product was directly
compared with the reference and its DNA amounts
(in pmoles) were automatically determined by BandScan.Detection of HIV-1 p24 antigen by BCA based on MMPs
The assay scheme is shown in Figure 1C. One hundred
μl of ten-fold serial dilutions of HIV-1 p24 antigen
(10,000 ~ 0.01 pg/ml) in 3% BSA, 0.2% Tween 20, PBS
(pH 7.4) and 40 μl diluted functionalized MMPs (1:100
diluted in PBS containing 1% BSA and 0.2% Tween 20)
were mixed in a tube of 1.5 ml for 60 min (1,400 oscilla-
tions/min) at 37°C, followed by 5 washes with PBS con-
taining 0.1% BSA, 0.05% Tween 20. After magnetic
separation, 0.5 μl functionalized GNPs and 3.3 μg tRNA
(66 mg/ml, Sigma-Aldrich, Inc., St. Louis, MO) in PBS
containing 10% BSA and 0.05% Tween 20 in a total vol-
ume of 200 μl were added in this reaction, followed by
mixing for 20 min (1400 oscillations/min). The mixture
was washed 8 times with PBS containing 0.1% BSA and
0.05% Tween 20 and 4 times with PBS. After magnetic
separation, 50 μl of Milli-Q distilled water was added
and the tubes were incubated at 80°C for 5 min to re-
lease bio-barcode DNA. One μl of the DNA solution
was used for PCR amplification. PCR products were
quantified as described in the previous section.Competing interests
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